|
|
||||||||||||||
Glaucoma Therapy LinksCouldn't open rss feed in /links/glaucoma_therapy_page_1.php Retinal Protection from Acute Glaucoma-Induced Ischemia ... Glaucoma Eye Disease - Glaucoma Therapy and a Proven Method That ... 10 critical issues that need to manage your glaucoma. Glaucoma Eye Disease - Glaucoma Therapy and a Proven Method That ... Wonder drugs from ganja - Britain approves cannabis-based medicine |
|
|||||||||||||
|
SLT Secrets Recommended Products | ||||||||||||||
| Glaucoma Therapy News | ||||||||||||||
Allergan Receives FDA Approval For LUMIGAN(R) 0.01% As First-Line Therapy Indicated For The Reduction Of Elevated ...Allergan, Inc. (NYSE:AGN) announced the United States Food and Drug Administration (FDA) has approved LUMIGAN® (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. LUMIGAN® 0.01% is an optimized reformulation of LUMIGAN® (bimatoprost ophthalmic solution) 0.03 ... Read more...FDA approves LUMIGAN for intraocular pressure reduction in open-angle glaucoma patientsAllergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved LUMIGAN (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Read more...Primary Organic Therapy Inc. is Approved to Operate a Medical Marijuana Dispensary in MaineWHITNEYVILLE, Maine, Sept. 1 /PRNewswire/ -- Primary Organic Therapy, a non-profit medical marijuana dispensary, proudly announces their selection by Maine's Department of Health and Human Services for operation in Whitneyville to serve Washington and Hancock counties. The new facility will be located at 90 Community Drive in Sanford, and will open for business in December of 2010. "We are ... Read more...Sight-Saving Research Halted By Stem Cell RulingARVO opposes the Federal District Court injunction that froze federal funding for human embryonic stem cell (hESC) researchThe Association for Research in Vision and Ophthalmology (ARVO), a professional organization of member scientists, opposes the Federal District Court injunction that froze federal funding for human embryonic stem cell (hESC) research. ARVO is troubled by this barrier to ... Read more...Allergan, Inc. Receives FDA Approval for LUMIGAN® 0.01% as First-Line Therapy Indicated for the Reduction of Elevated ...IRVINE, Calif.----Allergan, Inc. today announced the United States Food and Drug Administration has approved LUMIGAN® 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Read more... |
||||||||||||||
| Home · Sitemap | ||||||||||||||
